The premier of the Arvid Carlsson Award by Sahlgrenska Science Park took place during festive forms at this year’s life science event in Gothenburg on September 27th. Nobel laureate Arvid Carlsson presented the prize to Erik Gatenholm and Hector Martinez, CELLINK, at Park Annual, with around 500 participants in the life science business.
– Erik Gatenholm and Hector Martinez are driven entrepreneurs with the ambition to make life science industry more sustainable. They have developed CELLINK into one of Sweden’s growth rockets by consciously investing in building the right team and going global, says Charlotta Gummeson, CEO of Sahlgrenska Science Park.
The prize is to be awarded annually to an entrepreneur who drives progress towards human health and welfare. The jury’s motivation for Erik Gatenholm and Hector Martinez in 2017 reads:
Going to market with a Life Science product is known to take time in a complex
regulatory environment. Despite this the winners have built one of the fastest
growing Life Science companies in Sweden with an international and sustainable
mindset from the start. With a true entrepreneurial spirit they are influencing
others to believe in their ideas. With the future ahead of them, they dare to break
boundaries by collaborating and building a strong team for successful business
across the world.
The jury represents the business community, University of Gothenburg, Sahlgrenska University Hospital, Chalmers University of Technology, Västra Götaland Region, Business Region Gothenburg and Mölndal City. Jury members 2017 are:
Marianne Dicander Alexandersson, chairman of the Sahlgrenska Science Park
Stefan Bengtsson, Principal and CEO, Chalmers University of Technology
Eva Wiberg, Principal, University of Gothenburg
Cecilia Dalman Eek, Member of the City Council, City of Gothenburg, Vice Chairman SU
Patrik Karlsson, Member Regional Council, Västra Götaland Region
Håkan Ahlström, City Director, City of Mölndal
Ann-Marie Wennberg, Hospital Director Sahlgrenska University Hospital (SU)
Arvid Carlsson, awarded the Nobel Prize in Medicine in 2000 for his “discoveries regarding neurotransmitters” is still active in his company A. Carlsson Research at Sahlgrenska Science Park in Gothenburg today.
“I am very happy and proud to give name to an award that strengthens and praises entrepreneurship while emphasizing the importance of long-term and constant skills development,” says Arvid Carlsson.
“This is an amazing honor,” says Erik Gatenholm, CEO and one of the founders of CELLINK.
CELLINK has developed a 3D printer for human tissue, is the first bioink company in the world and the first bioprint company in Scandinavia. The ability to print organs and human tissues can create benefits for patients in many different areas. The ink, containing nanocellulose, has many important mechanical properties and is also sustainable.
Learn more here
Photo: Anna Hult
Text: Annika Åkervall